ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 154

Identification Of Autoimmune Disease Genes In Regions Under Selection In The Gullah African American Population Of South Carolina

Paula S. Ramos1, Nathan Titus2, Satria Sajuthi3, Jasmin Divers3, Yiqi Huang4, Uma Nayak5, Wei-Min Chen5, Kelly J. Hunt6, Diane L. Kamen7, Gary S. Gilkeson7, Jyotika K. Fernandes8, Ida J. Spruill8, W. Timothy Garvey9, Michèle M. Sale4 and Carl D. Langefeld3, 1Department of Medicine, Medical University of South Carolina, Charleston, SC, 2Wake Forest School of Medicine, Winston-Salem, NC, 3Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 4Department of Medicine and Center for Public Health Genomics, University of Virginia, Charlottesville, VA, 5Public Health Sciences, University of Virginia, Charlottesville, VA, 6Public Health Sciences, Medical University of South Carolina, Charleston, SC, 7Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC, 8Medical University of South Carolina, Charleston, SC, 9Department of Nutrition Sciences and Birmingham VA Medical Center, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: African-Americans, autoimmune diseases, health disparities and population studies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Most autoimmune diseases (ADs) are more prevalent in specific ethnic groups. We hypothesize that one reason for the ethnic disparity may be an effect of population-specific selection influencing the allele frequencies at some loci. Selection for specific alleles that improves fitness and survival in a specific environment can lead to increased disease risk in a different environment. Given the growing number of disease-associated loci in regions that show evidence of selection, identification of alleles under selection may provide insight into disease susceptibility.  Relative to other African-Americans (AA), the AA Gullah population has lower European admixture and higher ancestral homogeneity from the Sierra Leone area in Far-West Africa. The shorter genetic distance between the Gullahs and Sierra Leoneans suggests that population genetic signals, such as regions under recent selection, may be more easily detected in the Gullahs than in other African American (AA) populations. The goal of this study was to identify regions under recent positive selection in the Gullahs that may harbor risk loci for ADs.

Methods: We computed the cross population extended haplotype homozygosity test (XP-EHH) to identify alleles with higher than expected frequency relative to their haplotype length in one population relative to another. We compared 277 control Gullahs to 400 Sierra Leonean controls and to 203 HapMap Yorubans (YRI) from Nigeria. A total of 679,513 SNPs with MAF>5% met all statistical quality control criteria. Regions that met genome-wide significance ((|XP-EHH|>4, PResults: We identified multiple regions with evidence of recent selection. Over 20 regions showed evidence of selection between the Gullah and the Sierra Leoneans (|XP-EHH|>4, PDAB1 (Kawasaki disease), KCNH8 (Crohn’s disease, psoriasis), and LPP genes (vitiligo, celiac disease). Twenty four regions showed evidence of selection between the Gullah and the YRI, revealing an enrichment of genes involved in cytokine/chemokine mediated immunity (P-Bonferroni=0.0015), but only two regions were being selected for in the Gullahs, none of which has previously shown evidence of association with an AD. Regions associated with ADs showing evidence of selection in the YRI population include those of the the HLA region (all ADs), the CCR2 (celiac disease), and SMOC2 genes (vitiligo), with CCR2 also showing evidence of selection in the Sierra Leone population. This scan also identified the region around the APOL1 gene, which has been shown to be under selection and associated with multiple kidney diseases in AAs.

Conclusion: We have identified several risk alleles for ADs that are targets of recent positive selection in an AA population. Given the increased prevalence of several ADs in AAs and the homogeneity of the Gullahs, identification of these regions in the Gullahs has the potential to elucidate AD risks in AAs and help explain the ethnic disparity.


Disclosure:

P. S. Ramos,
None;

N. Titus,
None;

S. Sajuthi,
None;

J. Divers,
None;

Y. Huang,
None;

U. Nayak,
None;

W. M. Chen,
None;

K. J. Hunt,
None;

D. L. Kamen,
None;

G. S. Gilkeson,
None;

J. K. Fernandes,
None;

I. J. Spruill,
None;

W. T. Garvey,
None;

M. M. Sale,
None;

C. D. Langefeld,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-autoimmune-disease-genes-in-regions-under-selection-in-the-gullah-african-american-population-of-south-carolina/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology